Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Novel FOXG1 Mutations in Chinese Patients with Rett Syndrome or Rett-like Mental Retardation.

Identification of a de novo mutation of the FOXG1 gene and comprehensive analysis for molecular factors in Chinese FOXG1-related encephalopathies

Molecular characteristics of Chinese patients with Rett syndrome.

[Genetic Features and Mechanism of Rett Syndrome in Chinese Population].

PRRT2 mutations in a cohort of Chinese families with paroxysmal kinesigenic dyskinesia and genotype-phenotype correlation reanalysis in literatures.

Rett and Rett-like syndrome: Expanding the genetic spectrum to KIF1A and GRIN1 gene.

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

FOXG1 variants can be associated with milder phenotypes than congenital Rett syndrome with unassisted walking and language development

MECP2 and CDKL5 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

Rett Syndrome In China - Report Of 9 Patients

MECP2 Gene Mutation Analysis in Chinese Patients with Rett Syndrome

Methyl-CpG-binding protein 2 gene and CDKL5 gene mutation in patients with Rett syndrome: analysis of 177 Chinese pediatric patients

Report of a case with 14q12 triplication and literature review for FOXG1-related diseases

Mutational Analysis of MECP2 Gene in Rett Syndrome

Clinical Feature of Rett Syndrome and MeCP2 Genotype/phenotype Correlation Analysis

MECP2 Mutation Spectrum and Its Clinical Characteristics in a Chinese Cohort

Novel MEF2C Point Mutations in Chinese Patients with Rett (−like) Syndrome or Non-Syndromic Intellectual Disability: Insights into Genotype-Phenotype Correlation

Familial Cases and Male Cases with MECP2 Mutations

Clinical features and gene mutational spectrum of CDKL5 -related diseases in a cohort of Chinese patients

Clinical Research on Rett Syndrome: Central Hypoxemia and Hypokalemic Metabolic Alkalosis.

Analysis of the Parental Origin of MECP2 Mutations in Patients with Rett Syndrome